Release Date: 29/07/14 12:06 Summary: Sale of Goliath Prospect Price Sensitive: Yes Download Document 83.91KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%